Orchid Pharma’s arm inks MoU with overseas technology provider

04 Mar 2023 Evaluate

Orchid Pharma’s wholly owned subsidiary -- Orchid Bio-Pharma has entered into a Memorandum of Understanding (MoU) with an overseas technology provider for in-licensing 7ACA technology.

Earlier, Orchid Bio-Pharma had received approval to manufacture the product ‘7 ACA’ with a committed capacity of 1000 Metric Tonne Per Annum. This approval will help the company in backward integration, reduce dependency on sourcing from China and aid in improving margins.

Orchid Pharma, established as an export-oriented unit (EOU), is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing.

Orchid Pharma Share Price

723.40 -16.85 (-2.28%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×